MedWatch

Orphazyme launches investigation into dramatic and mysterious share price roller coaster

Orphazyme experienced significant turbulence on the US market on Thursday, where share price increases peaked at 1,400 percent with no explanation or forewarning. This rubbed off on the Danish exchange on Friday.

Photo: Orphazyme/PR

Prices of shares in biotech company Orphazyme have been through an inexplicable roller coaster since Thursday.

Orphazyme is listed on the Danish and US stock exchange, and its share price started fluctuating wildly in the US on Thursday when the share price skyrocketed, rising by almost 1,400 percent at one point. Trading was suspended 20 times, and it all ended with a 300 percent increase.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs